LETTER TO THE EDITOR
Very unusual expression of multiple aberrant T-cell markers in plasmablastic plasma cell myeloma
Gabriel K. Habermehl,
Gabriel K. Habermehl
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Jason D. Chesser,
Jason D. Chesser
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Karl S. Theil,
Karl S. Theil
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Heesun J. Rogers,
Corresponding Author
Heesun J. Rogers
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Correspondence
Heesun J. Rogers, Section of Hematopathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
Email: [email protected]
Search for more papers by this author
Gabriel K. Habermehl,
Gabriel K. Habermehl
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Jason D. Chesser,
Jason D. Chesser
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Karl S. Theil,
Karl S. Theil
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Search for more papers by this author Heesun J. Rogers,
Corresponding Author
Heesun J. Rogers
Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio
Correspondence
Heesun J. Rogers, Section of Hematopathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
Email: [email protected]
Search for more papers by this author
First published: 11 February 2019
No abstract is available for this article.
CONFLICT OF INTEREST
Nothing to report.
REFERENCES
- 1Inaba T, Shimazaki C, Sumikuma T, Nakagawa M. T-cell associated antigen-positive B-cell lymphoma. Leuk Lymphoma. 2001; 42(6): 1161-1171.
- 2Go JH. Aberrant CD3 expression in a relapsed plasma cell neoplasm. J Pathol Transl Med. 2018; 52(3): 202-205.
- 3Oliveira JL, Grogg KL, Macon WR, Dogan A, Feldman AL. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases. Am J Surg Pathol. 2012; 36(9): 1364-1370.
- 4Pan Z, Chen M, Zhang Q, et al. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall. Mod Pathol. 2018; 31(5): 718-731.
- 5Tang YL, Chau CY, Yap WM, Chuah KL. CD3 expression in plasma cell neoplasm (multiple myeloma): a diagnostic pitfall. Pathology. 2012; 44(7): 668-670.
- 6Ando Y, Maeshima AM, Fukuhara S, et al. CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity. Int J Hematol. 2018; 108(3): 344-347.
- 7Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005; 18(6): 806-815.
